Latvia vs Morocco: Cause of death, by non-communicable diseases, ages 5-14, male
Latvia
35.8%
in 2021
Morocco
36.1%
in 2021
Latvia rank
88th
Morocco rank
87th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Latvia
- Morocco
How they compare
Morocco currently reports 36.1% against 35.8% in Latvia, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Latvia ahead.
Latvia ranks 88th and Morocco ranks 87th of 185 countries.
Across the 3 decades both report, Latvia averaged higher in 2 and Morocco in 1.
Head to head by decade
| Decade | Latvia | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.4% | 21.3% | 12.2% | Latvia |
| 2010s | 49.6% | 34.8% | 14.7% | Latvia |
| 2020s | 35.1% | 36.7% | 1.6% | Morocco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Latvia or Morocco?
- Morocco, at 36.1% against 35.8% in Latvia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Latvia and Morocco?
- 0.3%, with Morocco ahead.
- How many years of comparable data are there for Latvia and Morocco?
- 6 years are reported by both, from 2000 to 2021.
- How do Latvia and Morocco rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Latvia ranks 88th and Morocco ranks 87th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.